Anne has overall responsibility for the management and performance of Health Tech Enterprise (HTE). Her role includes setting the strategic vision for the company, providing leadership to the team, developing the business plan and agreeing budgets. Anne has been actively involved in intellectual property management and commercialisation of life sciences technologies for over 25 years.
In addition to leading the HTE team, she is also Chair of Ablatus, a women’s health company, and co-founded Medovate, a medical device development company, in 2017.
“At HTE we are passionate about improving the quality and efficiency of healthcare services through the adoption of innovative new products and services. We are constantly scanning the market for leading-edge technologies that will benefit patients, and meet the needs of clinicians and payers within healthcare markets. We work alongside key opinion leaders and innovators within the healthcare community, providing that vital link between the business community and front-line services to ensure new ideas are taken up and adopted.
I feel privileged to have led the diverse and talented HTE team for the last 12 years. We bring together our wide range of skills with a focus on building strong client relationships and delivering successful innovation projects to the market.”
Anne joined HTE in 2005 from Cambridge Enterprise, the technology transfer office of the University of Cambridge where she focused primarily on technologies from the biological and chemical sciences and was involved in all aspects of technology commercialisation. Anne holds a PhD in chemistry from Strathclyde University.
